210 related articles for article (PubMed ID: 32593746)
1. Interleukin-6 and severity of COVID-19 patients in Hefei, China.
Zhao Z; Xie J; Yin M; Yang Y; Ding C; Gao Y; Ma X
Med Mal Infect; 2020 Oct; 50(7):629-631. PubMed ID: 32593746
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 as a potential biomarker of COVID-19 progression.
Ulhaq ZS; Soraya GV
Med Mal Infect; 2020 Jun; 50(4):382-383. PubMed ID: 32259560
[No Abstract] [Full Text] [Related]
3. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.
Hou H; Zhang B; Huang H; Luo Y; Wu S; Tang G; Liu W; Mao L; Mao L; Wang F; Sun Z
Clin Exp Immunol; 2020 Jul; 201(1):76-84. PubMed ID: 32365221
[TBL] [Abstract][Full Text] [Related]
4. First atypical case of 2019 novel coronavirus in Yan'an, China.
Hao W; Li M; Huang X
Clin Microbiol Infect; 2020 Jul; 26(7):952-953. PubMed ID: 32087323
[No Abstract] [Full Text] [Related]
5. Correlation analysis of the severity and clinical prognosis of 32 cases of patients with COVID-19.
Ding M; Zhang Q; Li Q; Wu T; Huang YZ
Respir Med; 2020 Jun; 167():105981. PubMed ID: 32421546
[No Abstract] [Full Text] [Related]
6. Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage.
Liu J; Liu Y; Xiang P; Pu L; Xiong H; Li C; Zhang M; Tan J; Xu Y; Song R; Song M; Wang L; Zhang W; Han B; Yang L; Wang X; Zhou G; Zhang T; Li B; Wang Y; Chen Z; Wang X
J Transl Med; 2020 May; 18(1):206. PubMed ID: 32434518
[TBL] [Abstract][Full Text] [Related]
7. Endotheliopathy Is Induced by Plasma From Critically Ill Patients and Associated With Organ Failure in Severe COVID-19.
Rauch A; Dupont A; Goutay J; Caplan M; Staessens S; Moussa M; Jeanpierre E; Corseaux D; Lefevre G; Lassalle F; Faure K; Lambert M; Duhamel A; Labreuche J; Garrigue D; De Meyer SF; Staels B; Van Belle E; Vincent F; Kipnis E; Lenting PJ; Poissy J; Susen S; ;
Circulation; 2020 Nov; 142(19):1881-1884. PubMed ID: 32970476
[No Abstract] [Full Text] [Related]
8. Follow-up of asymptomatic patients with SARS-CoV-2 infection.
Zhou X; Li Y; Li T; Zhang W
Clin Microbiol Infect; 2020 Jul; 26(7):957-959. PubMed ID: 32234453
[No Abstract] [Full Text] [Related]
9. Characteristics of laboratory indexes in COVID-19 patients with non-severe symptoms in Hefei City, China: diagnostic value in organ injuries.
Li T; Wang L; Wang H; Gao Y; Hu X; Li X; Zhang S; Xu Y; Wei W
Eur J Clin Microbiol Infect Dis; 2020 Dec; 39(12):2447-2455. PubMed ID: 32613308
[TBL] [Abstract][Full Text] [Related]
10. Evaluations of the serological test in the diagnosis of 2019 novel coronavirus (SARS-CoV-2) infections during the COVID-19 outbreak.
Lin D; Liu L; Zhang M; Hu Y; Yang Q; Guo J; Dai Y; Xu Y; Cai Y; Chen X; Huang K; Zhang Z
Eur J Clin Microbiol Infect Dis; 2020 Dec; 39(12):2271-2277. PubMed ID: 32681308
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 pneumonia: CD8
Jiang Y; Wei X; Guan J; Qin S; Wang Z; Lu H; Qian J; Wu L; Chen Y; Chen Y; Lin X
Clin Immunol; 2020 Sep; 218():108516. PubMed ID: 32574709
[TBL] [Abstract][Full Text] [Related]
12. Clinical and pathological investigation of patients with severe COVID-19.
Li S; Jiang L; Li X; Lin F; Wang Y; Li B; Jiang T; An W; Liu S; Liu H; Xu P; Zhao L; Zhang L; Mu J; Wang H; Kang J; Li Y; Huang L; Zhu C; Zhao S; Lu J; Ji J; Zhao J
JCI Insight; 2020 Jun; 5(12):. PubMed ID: 32427582
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of organ function in patients with severe COVID-19 infections.
Zhu Y; Du Z; Zhu Y; Li W; Miao H; Li Z
Med Clin (Barc); 2020 Sep; 155(5):191-196. PubMed ID: 32586669
[TBL] [Abstract][Full Text] [Related]
14. Preterm birth: Potential risk factor for greater COVID-19 severity?
Debevec T; Burtscher J; Millet GP
Respir Physiol Neurobiol; 2020 Sep; 280():103484. PubMed ID: 32599161
[No Abstract] [Full Text] [Related]
15. Prediction Model Based on the Combination of Cytokines and Lymphocyte Subsets for Prognosis of SARS-CoV-2 Infection.
Luo Y; Mao L; Yuan X; Xue Y; Lin Q; Tang G; Song H; Wang F; Sun Z
J Clin Immunol; 2020 Oct; 40(7):960-969. PubMed ID: 32661797
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil-to-Lymphocyte ratio as a potential biomarker for disease severity in COVID-19 patients.
Haghjooy Javanmard S; Vaseghi G; Manteghinejad A; Nasirian M
J Glob Antimicrob Resist; 2020 Sep; 22():862-863. PubMed ID: 32810639
[TBL] [Abstract][Full Text] [Related]
17. [Neutrophil to lymphocyte ratio as a prognostic marker in COVID-19].
Basbus L; Lapidus MI; Martingano I; Puga MC; Pollán J
Medicina (B Aires); 2020; 80 Suppl 3():31-36. PubMed ID: 32658845
[TBL] [Abstract][Full Text] [Related]
18. Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients.
Yu HQ; Sun BQ; Fang ZF; Zhao JC; Liu XY; Li YM; Sun XZ; Liang HF; Zhong B; Huang ZF; Zheng PY; Tian LF; Qu HQ; Liu DC; Wang EY; Xiao XJ; Li SY; Ye F; Guan L; Hu DS; Hakonarson H; Liu ZG; Zhong NS
Eur Respir J; 2020 Aug; 56(2):. PubMed ID: 32398307
[TBL] [Abstract][Full Text] [Related]
19. Clinical Characteristics of Patients with Severe Pneumonia Caused by the SARS-CoV-2 in Wuhan, China.
Wang Y; Zhou Y; Yang Z; Xia D; Hu Y; Geng S
Respiration; 2020; 99(8):649-657. PubMed ID: 32841948
[TBL] [Abstract][Full Text] [Related]
20. Immune characteristics distinguish patients with severe disease associated with SARS-CoV-2.
Li X; Liu Y; Li J; Sun L; Yang J; Xu F; Zhou J; Wan L; Xu X; Le A; Zhang W
Immunol Res; 2020 Dec; 68(6):398-404. PubMed ID: 32989677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
